BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Muth C, Kirchner H, van den Akker M, Scherer M, Glasziou PP. Current guidelines poorly address multimorbidity: pilot of the interaction matrix method. Journal of Clinical Epidemiology 2014;67:1242-50. [DOI: 10.1016/j.jclinepi.2014.07.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Aramrat C, Choksomngam Y, Jiraporncharoen W, Wiwatkunupakarn N, Pinyopornpanish K, Mallinson PAC, Kinra S, Angkurawaranon C. Advancing multimorbidity management in primary care: a narrative review. Prim Health Care Res Dev 2022;23:e36. [PMID: 35775363 DOI: 10.1017/S1463423622000238] [Reference Citation Analysis]
2 van den Akker M, Harder S, Dieckelmann M, Muth C. Multimedikation. Arzneimittel-Kompass 2022 2022. [DOI: 10.1007/978-3-662-66041-6_3] [Reference Citation Analysis]
3 Lühmann D, Thiesemann R, Scherer M. Multimorbide Patienten. Facharzt Allgemeinmedizin 2022. [DOI: 10.1016/b978-3-437-15280-1.00089-8] [Reference Citation Analysis]
4 Müller BS, Klaaßen-Mielke R, Gonzalez-Gonzalez AI, Grandt D, Hammerschmidt R, Köberlein-Neu J, Kellermann-Mühlhoff P, Trampisch HJ, Beckmann T, Düvel L, Surmann B, Flaig B, Ihle P, Söling S, Grandt S, Dinh TS, Piotrowski A, Meyer I, Karbach U, Harder S, Perera R, Glasziou P, Pfaff H, Greiner W, Gerlach FM, Timmesfeld N, Muth C; AdAM study group. Effectiveness of the application of an electronic medication management support system in patients with polypharmacy in general practice: a study protocol of cluster-randomised controlled trial (AdAM). BMJ Open 2021;11:e048191. [PMID: 34588245 DOI: 10.1136/bmjopen-2020-048191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Brünn R, Müller BS, Flaig B, Kellermann-Mühlhoff P, Karbach U, Söling S, Muth C, van den Akker M; AdAM Study consortium. "I must, and I can live with that": a thematic analysis of patients' perspectives on polypharmacy and a digital decision support system for GPs. BMC Fam Pract 2021;22:168. [PMID: 34418964 DOI: 10.1186/s12875-021-01517-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lai FTT, Beeler PE, Yip BHK, Cheetham M, Chau PYK, Chung RY, Wong ELY, Yeoh EK, Battegay E, Wong SYS. Comparing Multimorbidity Patterns Among Discharged Middle-Aged and Older Inpatients Between Hong Kong and Zurich: A Hierarchical Agglomerative Clustering Analysis of Routine Hospital Records. Front Med (Lausanne) 2021;8:651925. [PMID: 34368178 DOI: 10.3389/fmed.2021.651925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS. Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF). Eur Heart J Cardiovasc Pharmacother 2020:pvaa108. [PMID: 32941594 DOI: 10.1093/ehjcvp/pvaa108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vinjerui KH, Boeckxstaens P, Douglas KA, Sund ER. Prevalence of multimorbidity with frailty and associations with socioeconomic position in an adult population: findings from the cross-sectional HUNT Study in Norway. BMJ Open 2020;10:e035070. [PMID: 32546489 DOI: 10.1136/bmjopen-2019-035070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gimeno-Miguel A, Gracia Gutiérrez A, Poblador-Plou B, Coscollar-Santaliestra C, Pérez-Calvo JI, Divo MJ, Calderón-Larrañaga A, Prados-Torres A, Ruiz-Laiglesia FJ. Multimorbidity patterns in patients with heart failure: an observational Spanish study based on electronic health records. BMJ Open 2019;9:e033174. [PMID: 31874886 DOI: 10.1136/bmjopen-2019-033174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
10 Gonzalez AI GONZALEZ, Schmucker C, Nothacker J, Motschall E, Nguyen TS, Brueckle MS, Blom J, van den Akker M, Röttger K, Wegwarth O, Hoffmann T, Straus SE, Gerlach FM, Meerpohl JJ, Muth C. Health-related preferences of older patients with multimorbidity: an evidence map. BMJ Open 2019;9:e034485. [PMID: 31843855 DOI: 10.1136/bmjopen-2019-034485] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
11 Caughey GE, Shakib S, Barratt JD, Roughead EE. Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity. Drugs Aging 2019;36:471-9. [PMID: 30875020 DOI: 10.1007/s40266-019-00645-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hausmann D, Kiesel V, Zimmerli L, Schlatter N, von Gunten A, Wattinger N, Rosemann T. Sensitivity for multimorbidity: The role of diagnostic uncertainty of physicians when evaluating multimorbid video case-based vignettes. PLoS One 2019;14:e0215049. [PMID: 30970008 DOI: 10.1371/journal.pone.0215049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Eisele M, Adam W, Rakebrandt A, Boczor S, Blozik E, Träder JM, Störk S, Herrmann-Lingen C, Scherer M; RECODE-HF study group. Importance of comorbidities in the treatment of primary care patients with heart failure-Baseline results of the observational RECODE-HF Study. Fam Pract 2018;35:481-7. [PMID: 29385434 DOI: 10.1093/fampra/cmx135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ruiz-ruiz F, Medrano F, Santos-lozano J, Rodríguez-torres P, Navarro-puerto A, Calderón E. Tratamiento anticoagulante en pacientes médicos con situaciones clínicas complejas. Revista Clínica Española 2019;219:34-43. [DOI: 10.1016/j.rce.2018.04.007] [Reference Citation Analysis]
15 Ruiz-ruiz F, Medrano F, Santos-lozano J, Rodríguez-torres P, Navarro-puerto A, Calderón E. Anticoagulant treatment of medical patients with complex clinical conditions. Revista Clínica Española (English Edition) 2019;219:34-43. [DOI: 10.1016/j.rceng.2018.04.015] [Reference Citation Analysis]
16 Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS, Brueckle MS, Cesari M, Tinetti ME, Valderas JM. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med 2019;285:272-88. [PMID: 30357955 DOI: 10.1111/joim.12842] [Cited by in Crossref: 48] [Cited by in F6Publishing: 86] [Article Influence: 12.0] [Reference Citation Analysis]
17 Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S. [Multimorbidity management and the physician's daily clinical dilemma]. Internist (Berl) 2017;58:344-53. [PMID: 28246687 DOI: 10.1007/s00108-017-0200-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Catalá-López F, Alonso-Arroyo A, Page MJ, Hutton B, Tabarés-Seisdedos R, Aleixandre-Benavent R. Mapping of global scientific research in comorbidity and multimorbidity: A cross-sectional analysis. PLoS One 2018;13:e0189091. [PMID: 29298301 DOI: 10.1371/journal.pone.0189091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
19 Martinez-litago E, Martínez-velasco M, Muniesa-zaragozano M. Palliative care and end-of-life care for polypathological patients. Revista Clínica Española (English Edition) 2017;217:543-52. [DOI: 10.1016/j.rceng.2017.08.003] [Reference Citation Analysis]
20 Martinez-Litago E, Martínez-Velasco MC, Muniesa-Zaragozano MP. Palliative care and end-of-life care for polypathological patients. Rev Clin Esp (Barc) 2017;217:543-52. [PMID: 29029757 DOI: 10.1016/j.rce.2017.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
21 Nelson ML, McKellar KA, Munce S, Kelloway L, Hans PK, Fortin M, Lyons R, Bayley M. Addressing the Evidence Gap in Stroke Rehabilitation for Complex Patients: A Preliminary Research Agenda. Arch Phys Med Rehabil 2018;99:1232-41. [PMID: 28947162 DOI: 10.1016/j.apmr.2017.08.488] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
22 James JE. Reviving Cochrane's contribution to evidence-based medicine: bridging the gap between evidence of efficacy and evidence of effectiveness and cost-effectiveness. Eur J Clin Invest 2017;47:617-21. [DOI: 10.1111/eci.12782] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
23 Muche-Borowski C, Lühmann D, Schäfer I, Mundt R, Wagner HO, Scherer M; Guideline Group of the German College of General Practice and Family Medicine (DEGAM). Development of a meta-algorithm for guiding primary care encounters for patients with multimorbidity using evidence-based and case-based guideline development methodology. BMJ Open 2017;7:e015478. [PMID: 28645968 DOI: 10.1136/bmjopen-2016-015478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
24 Schellevis FG. Multimorbiditeit en polyfarmacie. Bijblijven 2017;33:331-338. [DOI: 10.1007/s12414-017-0245-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Zamborlini V, da Silveira M, Pruski C, Ten Teije A, Geleijn E, van der Leeden M, Stuiver M, van Harmelen F. Analyzing interactions on combining multiple clinical guidelines. Artif Intell Med 2017;81:78-93. [PMID: 28410780 DOI: 10.1016/j.artmed.2017.03.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
26 Nelson MLA, Mckellar KA, Yi J, Kelloway L, Munce S, Cott C, Hall R, Fortin M, Teasell R, Lyons R. Stroke rehabilitation evidence and comorbidity: a systematic scoping review of randomized controlled trials. Topics in Stroke Rehabilitation 2017;24:374-80. [DOI: 10.1080/10749357.2017.1282412] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
27 Blom JW, El Azzi M, Wopereis DM, Glynn L, Muth C, van Driel ML. Reporting of patient-centred outcomes in heart failure trials: are patient preferences being ignored? Heart Fail Rev 2015;20:385-92. [PMID: 25690985 DOI: 10.1007/s10741-015-9476-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
28 Buffel du Vaure C, Ravaud P, Baron G, Barnes C, Gilberg S, Boutron I. Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis. BMJ Open 2016;6:e010119. [PMID: 27006342 DOI: 10.1136/bmjopen-2015-010119] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 10.3] [Reference Citation Analysis]
29 James JE. Healing Practices and Evidence-Based Medicine. The Health of Populations 2016. [DOI: 10.1016/b978-0-12-802812-4.00010-2] [Reference Citation Analysis]
30 Kuluski K, Tracy CS, Upshur RE. Perceived risk factors of health decline: a qualitative study of hospitalized patients with multimorbidity. Risk Manag Healthc Policy 2015;8:63-72. [PMID: 25960683 DOI: 10.2147/RMHP.S79720] [Reference Citation Analysis]
31 Negewo NA, McDonald VM, Gibson PG. Comorbidity in chronic obstructive pulmonary disease. Respir Investig 2015;53:249-58. [PMID: 26521102 DOI: 10.1016/j.resinv.2015.02.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
32 Muth C, van den Akker M, Blom JW, Mallen CD, Rochon J, Schellevis FG, Becker A, Beyer M, Gensichen J, Kirchner H, Perera R, Prados-Torres A, Scherer M, Thiem U, van den Bussche H, Glasziou PP. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med 2014;12:223. [PMID: 25484244 DOI: 10.1186/s12916-014-0223-1] [Cited by in Crossref: 144] [Cited by in F6Publishing: 158] [Article Influence: 18.0] [Reference Citation Analysis]